Achiko Logo cropped.jpg
Achiko AG Announces Corporate Update Webcast
November 16, 2022 10:38 ET | Achiko AG
ZURICH, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare technology company that is developing new...
Achiko Logo cropped.jpg
Achiko AG Production and Company Update
November 02, 2022 07:34 ET | Achiko AG
Completing Production Pilot for Generation 2 of AptameX™ as a Precursor to Mass Commercial ProductionExpect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of...
Achiko Logo cropped.jpg
Achiko AG Appoints New Chief Financial Officer
October 07, 2022 07:30 ET | Achiko AG
ZURICH, Switzerland, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare...
Achiko Logo cropped.jpg
Achiko AG Publication of Annual Report and Annual Financial Statements 2021 to Occur by June 6, 2022
May 31, 2022 07:30 ET | Achiko AG
ZURICH, Switzerland, May 31, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces that...
Achiko Logo cropped.jpg
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by May 31, 2022
April 29, 2022 07:30 ET | Achiko AG
ZURICH, Switzerland, April 29, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that...
Achiko Logo cropped.jpg
Achiko Secures up to USD$12.6 Million Equity and Debt Financing Lines with RiverFort Over Three Years
April 20, 2022 07:30 ET | Achiko AG
ZURICH, Switzerland, April 20, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces the...
AptameX™ :  Achiko’s DNA Aptamer-Based Covid-19 Rapid Test
Achiko AG’s Shares Begin Trading on the OTCQB Market
December 20, 2021 07:30 ET | Achiko AG
ZURICH, Switzerland, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468; www.achiko.com) (“Achiko”, the “Company”), a global healthtech company which has...
Achiko Logo cropped.jpg
Achiko’s Commercialization Update: Optimized Second-Generation Covid-19 Diagnostic Test Receives Full Product Registration Approval in Indonesia
December 08, 2021 07:50 ET | Achiko AG
Second-generation of AptameX, Achiko’s innovative DNA aptamer diagnostic test for Covid-19 has received full approval in Indonesia for five yearsProduction of the second-generation AptameX kits to...
Achiko Logo cropped.jpg
Achiko’s Covid-19 DNA Aptamer-Based Rapid Testing Platform Update
November 24, 2021 07:30 ET | Achiko AG
Pilot program in Indonesia is on track with positive results and support for Achiko’s proprietary, low-cost rapid Covid-19 diagnostic test, AptameX, alongside its sister digital passporting service...
Achiko Logo cropped.jpg
Achiko Secures Initial Sales of AptameX Covid-19 Diagnostic Test
October 27, 2021 07:30 ET | Achiko AG
Achiko has received its first purchase order in Jakarta and Bali in Indonesia.The orders translate to 20,000 tests - while modest in size, the order is expected to pave the way to rapid adoption by...